Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer
about
High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progressionAdvanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancerKi-67 as a prognostic marker in early-stage non-small cell lung cancer in Asian patients: a meta-analysis of published studies involving 32 studiesSignificance of system L amino acid transporter 1 (LAT-1) and 4F2 heavy chain (4F2hc) expression in human developing intestinesClinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancerPrognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.Molecular modeling and ligand docking for solute carrier (SLC) transportersMonoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.CD98 increases renal epithelial cell proliferation by activating MAPKs.A novel five-antibody immunohistochemical test for subclassification of lung carcinoma.Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPETIncreased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.Cancer stratification by molecular imaging.LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancerExpression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myelomaAspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumorsL-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor geneReciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.Clinical significance of coexpression of L-type amino acid transporter 1 (LAT1) and ASC amino acid transporter 2 (ASCT2) in lung adenocarcinomaPrognostic significance of L-type amino acid transporter 1 (LAT1) expression in patients with ovarian tumors.Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors.Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancerPrognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer.Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1Immunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells.Efficacy of system l amino acid transporter 1 inhibition as a therapeutic target in esophageal squamous cell carcinoma.Quantification of tryptophan transport and metabolism in lung tumors using PET.Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer.A systemic review of PET and biology in lung cancerPrognostic and predictive factors in resected non-small-cell lung cancer.L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer.Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use?The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma.Targeting L-type amino acid transporter 1 for anticancer therapy: clinical impact from diagnostics to therapeutics.LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
P2860
Q21133895-CF4C86CD-0692-4CAB-A2A1-4FFE11996A2EQ27025770-2DB2DE86-3825-4D84-B404-D5A3E9AEEA28Q30657753-C9FBD9A9-0E2D-4E9A-8348-92AA0ED8A013Q33484202-B881CD29-2F5C-4C8D-B62C-F6371B149FE3Q33592952-D76609E6-1DDD-414E-B509-85F6F4C24D3CQ33613632-43AF33F4-FAB3-471A-8BA2-9357EDC5E4F0Q33751096-9E06A888-5643-4AD2-B45A-EE0D9B9F7A03Q33797210-80013CBF-B8A6-4DF5-90DB-357D99CD8CABQ34328557-2650A31F-2ECF-4AB1-9F44-1355D5D9F6BFQ34980292-99685BA9-60BB-4CE4-9963-D769EA2B708BQ35021768-FCA5DF29-172E-4A95-9497-F232454B9696Q35028079-E3DB27CA-A10A-43F0-97BA-A2224A4F4B75Q35380664-E1E6CC56-188F-452B-901C-7BC687E7BA5CQ35485542-53BDD588-1349-4886-AA4B-15FBFC2BCC56Q35713446-AD8F6888-9EAA-49BD-B614-E1F3D9C2E00DQ35754246-C68FE9B9-C5F5-4C36-B625-2410088A846EQ35757977-EE348690-0D5A-48E7-BE87-32A5B46BC403Q35774573-DDA18DD9-AE43-47C3-AC61-66557DC7CA07Q35857671-21DBE377-1F76-429E-AF60-524B164A98D6Q35893126-B22B0CF4-53DE-4C20-9B26-18CDB9C89A8CQ35941321-CB82118E-5BCE-4370-969D-8DD34E6D207CQ35941337-3A3252BF-0321-4D80-B6E3-D0F4832C0373Q36029393-20F7628C-5F3A-4D52-ACE6-E9CE6E9F3C39Q36045175-FFCF9201-3632-46AB-AAEA-3DA175796189Q36166827-EC0F977E-2799-4BD3-A68D-8BD9B99BA032Q36244067-3E47D4B3-105C-4032-8282-46608D8337C4Q36746299-FF714632-760F-467B-AA84-FA7E977E5A2FQ36747640-FE5ED8A5-8BD3-4366-BBB3-28376E25CCD1Q37343451-CE98C79A-F061-40D0-80A0-F7845A3138A5Q37375216-D1F65DB7-3502-43EC-8D8B-3BF3D0690798Q37445396-3F758A1D-4CC0-445B-8D66-9DDFA68C6AEDQ37711666-3782BFF9-2913-4CB5-BE34-1B468AB70EE6Q37711691-2FD835F8-58CB-4154-A642-16EEEEC94CE0Q37929599-AE756C26-CAF7-4E97-8D11-A37B3344EF19Q38089884-CC2E3DC0-14FE-445C-BD95-2C7DA2FE5437Q38292729-459E57C4-EF1B-40C6-A14F-7A5E82AB9BB7Q38323055-6A16520C-5898-435F-A108-6BF7875561D8Q38396468-F5BACE9C-0788-47E6-B91B-429FC004FE8CQ38476583-C55E875E-83B9-4096-9EFE-74E35B2B7EAFQ38754089-24ABC162-2297-4597-A896-A58CFA8418E6
P2860
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@ast
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@en
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@nl
type
label
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@ast
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@en
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@nl
prefLabel
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@ast
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@en
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@nl
P2093
P2860
P3181
P356
P1476
Prognostic significance of L-t ...... -III nonsmall cell lung cancer
@en
P2093
N Yanagitani
P2860
P2888
P3181
P356
10.1038/SJ.BJC.6604235
P407
P577
2008-02-26T00:00:00Z
P5875
P6179
1034990628